KAIST and the Korea Research Institute of Chemical Technology have jointly developed the world’s first new ‘CRISPR ...

Analysts are intrested in these 5 stocks: ( ($DECK) ), ( ($CRDO) ), ( ($CRSP) ), ( ($AVAV) ) and ( ($ANF) ). Here is a breakdown of their recent ...

By upregulating the expression of the lone functioning copy of SCN2A, scientists addressed deficient brain signaling and reduced seizures.

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

Completed patient enrollment within nine months with nearly half enrolled from the U.S.Expect to report Phase 3 topline data in the first half of ...

Forget the glorious successes of past breakthroughs—the real justification for research investment is what we get for our ...

From the currently used sputum testing, soon tuberculosis screening can be done via a simple tongue swab, according to a ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...